ReviewSexually transmitted infections2013
Characterising the progress in HIV/AIDS research in the Middle East and North Africa.
Review in Sexually transmitted infections, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Sexually transmitted infection knowledge and attitudes among Muslim women worldwide: a systematic review.Sexual and reproductive health matters · 2020Pooled it
- Epidemiology ofJournal of global health · 2019Pooled it
- HIV epidemiology among female sex workers and their clients in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions.BMC medicine · 2019Pooled it
- HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.PLoS medicine · 2014Pooled it
- Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa.Viruses · 2026Article
- Perceptions of Arab researchers regarding publishing scientific research: A cross-sectional study.Accountability in research · 2026Article
- Trends of HIV indicators in Egypt from 1990 to 2021: time-series analysis and forecast toward UNAIDS 90-90-90 targets.BMC public health · 2023Article
- Muslim women's perspectives on the barriers to sexually transmitted infections testing and diagnosis in Saudi Arabia.Frontiers in public health · 2023Article
- The realities of HIV prevention. A closer look at facilitators and challenges faced by HIV prevention programmes in Sudan and Yemen.Global health action · 2019Article
- Herpes Simplex Virus Type 2 Seroprevalence Among Different National Populations of Middle East and North African Men.Sexually transmitted diseases · 2018Article
- Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward.International journal of health policy and management · 2017Article
- HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis.BMC public health · 2016Article
- Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.Journal of the International AIDS Society · 2016Review
- Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa.World journal of virology · 2015Review
- Women and HIV: the urgent need for more research and policy attention in the Middle East and North Africa region.Journal of the International AIDS Society · 2015Article
- The emerging face of the HIV epidemic in the Middle East and North Africa.Current opinion in HIV and AIDS · 2014Review
- Women, culture and the HIV epidemic in MENA.Journal of the International AIDS Society · 2014Article
- Why is the number of HIV/AIDS-related publications low in the MENA region?Sexually transmitted infections · 2013Article
- HIV and other sexually transmitted infection research in the Middle East and North Africa: promising progress?Sexually transmitted infections · 2013Article
- Epidemiology of HIV in the Eastern Province of Saudi Arabia: A 10-year Retrospective Analysis.Saudi journal of medicine & medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe Middle East and North Africa (MENA) region is perceived to have limited HIV data. The objective of this study was to quantitatively characterise the progress in HIV research in this region since the discovery of the epidemic.
methodsFour indices were defined and implemented to measure the progress of HIV research using the PubMed, Embase, MENA HIV/AIDS Epidemiology Synthesis Project and US Census Bureau HIV/AIDS Surveillance databases. The four indices provide complementary measures to characterise different aspects of the progress of HIV research.
resultsA total of 2118, 2352, 683 and 4889 records were identified through the PubMed, the Embase, the Synthesis Project and the HIV Prevalence indices, respectively. The proportion of the total global HIV records that relate to MENA is 1.2%. Overall, the indices show steady progress in the number of new records every year, with an accelerated pace in the last few years. The rate of progress in MENA was also higher than the rate of progress in HIV records globally. There is no evidence so far of stabilisation or a peak in the number of new records year by year. About half of the records were produced after the year 2005. The number of records shows large heterogeneity across countries.
conclusionsMENA has witnessed a rapid growth in HIV research over the last decade. However, there are still large gaps in HIV scientific evidence in the region, and the progress is far from being uniform across countries. Ongoing and future research needs to be geared towards academic standard and production of scientific publications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.